Aehr Test Systems (NASDAQ:AEHR) Director Rhea Posedel Sells 5,973 Shares

Aehr Test Systems (NASDAQ:AEHR) Director Rhea Posedel sold 5,973 shares of the company’s stock in a transaction on Friday, August 14th. The shares were sold at an average price of $140.00, for a total value of $836,220.00. Following the transaction, the director directly owned 381,989 shares in the company, valued at $53,478,460. This trade represents a 1.54% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Aehr Test Systems Stock Up 8.7%

Shares of AEHR stock opened at $134.06 on Friday. The firm has a market cap of $4.37 billion, a price-to-earnings ratio of -558.56 and a beta of 3.10. Aehr Test Systems has a 12 month low of $16.38 and a 12 month high of $147.40. The stock has a 50-day moving average price of $92.83 and a 200 day moving average price of $71.45.

Aehr Test Systems News Roundup

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Jefferies initiated coverage with a bullish view, helping drive renewed investor interest. The analyst reportedly described the price target as conservative and identified additional potential catalysts that were not included in the model. Jefferies Initiates Coverage on Aehr Test Systems
• Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat business supports demand for the company’s FOX systems and strengthens its position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
• Positive Sentiment: Recent company updates pointed to record quarterly bookings of $60.7 million, a backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide revenue visibility and support the investment case tied to rising AI-chip testing demand. Aehr AI Order and WLBI Opportunity
• Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 19. The event could provide further commentary on backlog conversion and fiscal 2027 execution, but no new financial information was announced. Aehr to Participate in Needham Conference
• Negative Sentiment: Several insiders sold shares after AEHR’s sharp rally. The transactions included the CEO’s sale of 40,000 shares for about $5.2 million, the COO’s sale of 15,000 shares for roughly $2.0 million, and additional director and executive sales. Although insiders retained sizable positions—and the CEO sale came from a trust—such activity may signal profit-taking and add selling pressure. Aehr CEO Share Sale
• Negative Sentiment: One analyst began coverage on a bearish note, highlighting the risk that expectations have become difficult to meet after the stock’s extraordinary advance. AEHR’s elevated valuation and dependence on continued AI order growth leave it vulnerable if bookings, backlog conversion or execution disappoints. Bearish Analyst Initiation

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the business. Freestone Grove Partners LP acquired a new stake in shares of Aehr Test Systems during the 2nd quarter worth about $189,000. Jupiter Topco LLC acquired a new position in Aehr Test Systems in the second quarter valued at about $1,172,000. AWM Investment Company Inc. bought a new stake in Aehr Test Systems during the second quarter worth about $36,004,000. Legal & General Group Plc acquired a new stake in Aehr Test Systems during the second quarter worth about $2,288,000. Finally, The Manufacturers Life Insurance Company acquired a new stake in Aehr Test Systems during the second quarter worth about $1,007,000. Institutional investors own 69.69% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have commented on AEHR. Zacks Research raised shares of Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a report on Friday, July 17th. Jefferies Financial Group began coverage on Aehr Test Systems in a research note on Thursday. They issued a “buy” rating and a $175.00 price target on the stock. Lake Street Capital restated a “buy” rating and issued a $110.00 price target on shares of Aehr Test Systems in a research report on Wednesday, July 15th. Craig Hallum reaffirmed a “buy” rating and set a $125.00 price objective on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Finally, Weiss Ratings downgraded Aehr Test Systems from a “sell (d)” rating to a “sell (e+)” rating in a report on Wednesday, July 29th. Three analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Aehr Test Systems currently has a consensus rating of “Buy” and a consensus price target of $136.67.

About Aehr Test Systems

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.